Low dose aspirin after ischemic stroke associated with antiphospholipid syndrome

Neurology. 2003 Jul 8;61(1):111-4. doi: 10.1212/01.wnl.0000072324.59029.92.

Abstract

The authors describe course and outcome of eight patients with ischemic stroke as the first thrombotic manifestation of antiphospholipid syndrome who received low-dose aspirin as prophylactic treatment. During 8.9 years of follow-up, two patients had a recurrent stroke. Recurrent stroke rate per 100 patient-years on aspirin was 3.5 (95% CI 0.4 to 12.5).

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anticoagulants / therapeutic use
  • Antiphospholipid Syndrome / complications
  • Antiphospholipid Syndrome / drug therapy*
  • Aspirin / therapeutic use*
  • Brain Ischemia / drug therapy
  • Brain Ischemia / etiology
  • Brain Ischemia / prevention & control*
  • Female
  • Follow-Up Studies
  • Humans
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Secondary Prevention
  • Stroke / drug therapy
  • Stroke / etiology
  • Stroke / prevention & control*
  • Treatment Outcome

Substances

  • Anticoagulants
  • Platelet Aggregation Inhibitors
  • Aspirin